ESOMEPRAZOLE MAGNESIUM DIHYDRATE

ESOMEPRAZOLE MAGNESIUM DIHYDRATE was reported 14811 times

ESOMEPRAZOLE MAGNESIUM DIHYDRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL FLUID ANALYSIS 25 0.2874
1 HAEMORRHAGE FOETAL 15 0.2830
2 NEUROLOGIC NEGLECT SYNDROME 151 0.2716
3 EJECTION FRACTION 137 0.2358
4 SENSITISATION 176 0.2319
5 BRONCHIAL NEOPLASM 27 0.1985
6 CAROTID ARTERY THROMBOSIS 152 0.1790
7 CARDIOSPASM 92 0.1649
8 FOETAL ANAEMIA 18 0.1374
9 POST CHOLECYSTECTOMY SYNDROME 38 0.1343
10 IMMUNISATION 56 0.1290
11 NIPPLE SWELLING 31 0.1235
12 PALMOPLANTAR KERATODERMA 89 0.1228
13 HEPATOJUGULAR REFLUX 19 0.1145
14 ADJUSTMENT DISORDER 147 0.1131
15 POLYCYSTIC OVARIES 174 0.1121
16 GRANULOCYTE COUNT INCREASED 38 0.0938
17 BRONCHIAL HAEMORRHAGE 27 0.0865
18 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 67 0.0840
19 VIRAL TEST POSITIVE 28 0.0771
20 ELECTROCARDIOGRAM Q WAVE ABNORMAL 18 0.0769
21 HUMAN RHINOVIRUS TEST POSITIVE 28 0.0751
22 ENDOMETRIAL ABLATION 26 0.0728
23 NASAL TURBINATE HYPERTROPHY 27 0.0716
24 JAW CLICKING 15 0.0704
25 PNEUMONIA HAEMOPHILUS 34 0.0700
26 BLOOD IMMUNOGLOBULIN A INCREASED 37 0.0686
27 TENOSYNOVITIS STENOSANS 38 0.0682
28 ASPARTATE AMINOTRANSFERASE 16 0.0656
29 PERSONALITY DISORDER 158 0.0603
30 EJECTION FRACTION ABNORMAL 70 0.0571
31 ELECTRIC SHOCK 46 0.0537
32 CEREBRAL ARTERY THROMBOSIS 27 0.0525
33 BUNION OPERATION 29 0.0517
34 NEPHRITIC SYNDROME 16 0.0516
35 SYNOVIAL DISORDER 23 0.0505
36 BRAIN SCAN ABNORMAL 28 0.0502
37 RHEUMATOID NODULE 136 0.0493
38 GLOMERULAR FILTRATION RATE INCREASED 40 0.0484
39 VITAMIN B12 INCREASED 38 0.0477
40 ATRIAL TACHYCARDIA 93 0.0442
41 GRANULOMA SKIN 36 0.0438
42 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 30 0.0427
43 RHINITIS ALLERGIC 189 0.0424
44 OBSTRUCTIVE SLEEP APNOEA SYNDROME 61 0.0418
45 DACTYLITIS 40 0.0407
46 PRURITUS GENITAL 91 0.0386
47 PHYSICAL DECONDITIONING 95 0.0369
48 MULTI-ORGAN DISORDER 69 0.0350
49 RHEUMATOID FACTOR INCREASED 37 0.0331
50 NEPHRECTOMY 49 0.0330
51 OCCULT BLOOD 17 0.0324
52 PRODUCT USED FOR UNKNOWN INDICATION 40 0.0318
53 PANCREATIC NEUROENDOCRINE TUMOUR 17 0.0265
54 CAROTID ARTERY OCCLUSION 96 0.0263
55 INTERVERTEBRAL DISCITIS 49 0.0260
56 BLOOD PARATHYROID HORMONE DECREASED 38 0.0256
57 ALLERGY TO CHEMICALS 31 0.0249
58 CAROTID ARTERIOSCLEROSIS 25 0.0242
59 ASPARTATE AMINOTRANSFERASE ABNORMAL 35 0.0230
60 HEMIPLEGIA 189 0.0227
61 HYPERTENSIVE NEPHROPATHY 24 0.0225
62 NASAL DISCHARGE DISCOLOURATION 31 0.0225
63 TENOSYNOVITIS 61 0.0221
64 SLEEP TERROR 92 0.0218
65 SCLERITIS 34 0.0212
66 TENSION HEADACHE 91 0.0211
67 MAST CELL ACTIVATION SYNDROME 29 0.0207
68 URINE LEUKOCYTE ESTERASE POSITIVE 14 0.0200
69 CATARRH 18 0.0199
70 SENSORY LOSS 159 0.0197
71 RHONCHI 27 0.0195
72 DENTAL RESTORATION FAILURE 14 0.0194
73 JOINT NOISE 38 0.0193
74 BRONCHIAL DISORDER 30 0.0193
75 HEPATITIS VIRAL 15 0.0187
76 WHITE BLOOD CELLS URINE POSITIVE 35 0.0186
77 SYSTOLIC DYSFUNCTION 19 0.0180
78 PANNICULITIS 42 0.0173
79 GANGRENE 103 0.0171
80 AFFECT LABILITY 160 0.0166
81 SYNOVIAL CYST 75 0.0162
82 MOTOR DYSFUNCTION 161 0.0158
83 BLOOD TEST ABNORMAL 219 0.0156
84 CREPITATIONS 46 0.0154
85 HELICOBACTER GASTRITIS 19 0.0153
86 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 16 0.0151
87 NIPPLE PAIN 30 0.0147
88 COORDINATION ABNORMAL 203 0.0145
89 BREATH SOUNDS ABNORMAL 71 0.0144
90 DIABETIC NEPHROPATHY 31 0.0141
91 TONGUE BITING 29 0.0141
92 DRUG TOLERANCE DECREASED 39 0.0139
93 MAJOR DEPRESSION 101 0.0138
94 SLEEP APNOEA SYNDROME 259 0.0136
95 CARPAL TUNNEL SYNDROME 188 0.0134
96 ARTERIAL OCCLUSIVE DISEASE 104 0.0132
97 MUSCLE SPASTICITY 162 0.0132
98 ESSENTIAL HYPERTENSION 24 0.0131
99 AREFLEXIA 35 0.0131
100 PLEURITIC PAIN 36 0.0130
101 RESPIRATORY TRACT CONGESTION 198 0.0124
102 DEMYELINATION 51 0.0124
103 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 204 0.0120
104 ANAEMIA MACROCYTIC 25 0.0117
105 NEPHROSCLEROSIS 13 0.0117
106 NEPHROPATHY 107 0.0114
107 FIBROMYALGIA 276 0.0113
108 CHRONIC KIDNEY DISEASE 862 0.0113
109 RENAL ATROPHY 14 0.0112
110 FACIAL PAIN 99 0.0111
111 SINUS CONGESTION 149 0.0110
112 END STAGE RENAL DISEASE 199 0.0109
113 CUSHINGOID 35 0.0109
114 VITAMIN B12 DEFICIENCY 44 0.0109
115 HAEMATOMA MUSCLE 13 0.0108
116 BLOOD PRESSURE DIASTOLIC DECREASED 80 0.0108
117 BURNS SECOND DEGREE 19 0.0108
118 MONOCYTE COUNT INCREASED 39 0.0107
119 GASTRIC POLYPS 24 0.0106
120 RED BLOOD CELL SEDIMENTATION RATE INCREASED 113 0.0102
121 DIASTOLIC DYSFUNCTION 31 0.0100
122 THROAT CLEARING 37 0.0099
123 HEMIPARESIS 164 0.0097
124 ENTHESOPATHY 15 0.0096
125 SUBARACHNOID HAEMORRHAGE 97 0.0095
126 CARDIAC DISCOMFORT 19 0.0094
127 VASCULITIS 109 0.0093
128 SEDATION 240 0.0092
129 MALNUTRITION 101 0.0090
130 FULL BLOOD COUNT ABNORMAL 95 0.0090
131 ANTINUCLEAR ANTIBODY POSITIVE 29 0.0089
132 BLOOD PRESSURE SYSTOLIC DECREASED 40 0.0088
133 ULCER 138 0.0087
134 NEPHROGENIC ANAEMIA 40 0.0086
135 SKIN HAEMORRHAGE 127 0.0086
136 PSEUDOMONAL SEPSIS 15 0.0086
137 EPIGASTRIC DISCOMFORT 33 0.0084
138 VENTRICULAR HYPOKINESIA 27 0.0084
139 POST-TRAUMATIC STRESS DISORDER 55 0.0082
140 CHOLECYSTITIS ACUTE 46 0.0081
141 HYPOTHYROIDISM 252 0.0079
142 NIGHTMARE 273 0.0079
143 GRANULOMA 27 0.0078
144 EATING DISORDER 166 0.0078
145 VENTRICULAR TACHYCARDIA 127 0.0077
146 INGROWING NAIL 18 0.0076
147 LOSS OF EMPLOYMENT 23 0.0076
148 TENDERNESS 79 0.0076
149 FOOT DEFORMITY 84 0.0076
150 RENAL INJURY 222 0.0075
151 CHRONIC SINUSITIS 28 0.0075
152 BLOOD URIC ACID INCREASED 43 0.0074
153 PERICARDITIS 124 0.0074
154 REBOUND ACID HYPERSECRETION 22 0.0073
155 CYTOLYTIC HEPATITIS 24 0.0072
156 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 19 0.0071
157 SKIN NECROSIS 37 0.0071
158 JOINT EFFUSION 49 0.0071
159 NEPHROLITHIASIS 325 0.0071
160 BLOOD PRESSURE DIASTOLIC ABNORMAL 18 0.0071
161 RHINITIS 57 0.0071
162 NERVE INJURY 78 0.0070
163 SINUS DISORDER 137 0.0069
164 TUBULOINTERSTITIAL NEPHRITIS 129 0.0069
165 CAROTID ARTERY STENOSIS 24 0.0069
166 LEFT VENTRICULAR HYPERTROPHY 29 0.0068
167 SEROTONIN SYNDROME 130 0.0068
168 RHEUMATOID FACTOR POSITIVE 39 0.0067
169 DYSPNOEA AT REST 19 0.0066
170 SNEEZING 147 0.0065
171 BLOOD PRESSURE SYSTOLIC ABNORMAL 16 0.0065
172 LUNG OPACITY 17 0.0064
173 PULMONARY CONGESTION 84 0.0064
174 ANOSMIA 92 0.0063
175 ANAL ABSCESS 34 0.0063
176 OBSTRUCTIVE AIRWAYS DISORDER 70 0.0063
177 GASTROOESOPHAGEAL REFLUX DISEASE 501 0.0062
178 TOOTH INFECTION 82 0.0062
179 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 51 0.0062
180 MIOSIS 49 0.0061
181 HYPERPARATHYROIDISM SECONDARY 15 0.0060
182 MUSCLE CONTRACTIONS INVOLUNTARY 21 0.0060
183 APHASIA 179 0.0059
184 LARGE INTESTINE POLYP 41 0.0059
185 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 14 0.0059
186 ANGIOEDEMA 260 0.0059
187 PHLEBITIS 30 0.0059
188 RHINALGIA 16 0.0058
189 TEMPERATURE INTOLERANCE 60 0.0058
190 CATHETER SITE PAIN 15 0.0058
191 BLOOD IMMUNOGLOBULIN E INCREASED 14 0.0058
192 EYE HAEMORRHAGE 77 0.0058
193 HYPOPNOEA 20 0.0058
194 DYSLIPIDAEMIA 29 0.0057
195 INFUSION SITE PRURITUS 18 0.0057
196 ATELECTASIS 55 0.0057
197 RALES 33 0.0057
198 FOOT OPERATION 28 0.0057
199 PULMONARY TOXICITY 40 0.0057
200 POLYP 37 0.0056
201 SWOLLEN TONGUE 174 0.0056
202 NEUTROPHIL COUNT INCREASED 57 0.0056
203 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 36 0.0055
204 VITAMIN D DEFICIENCY 54 0.0055
205 DRUG DELIVERY SYSTEM MALFUNCTION 28 0.0055
206 HEPATOSPLENOMEGALY 14 0.0054
207 KIDNEY INFECTION 107 0.0054
208 THYROID DISORDER 84 0.0054
209 ADRENAL INSUFFICIENCY 66 0.0054
210 INJECTION SITE HYPERSENSITIVITY 17 0.0054
211 HEPATIC PAIN 23 0.0054
212 C-REACTIVE PROTEIN INCREASED 195 0.0054
213 HYPOMAGNESAEMIA 73 0.0052
214 CYSTITIS 166 0.0052
215 DIPLOPIA 132 0.0051
216 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 243 0.0051
217 CONTRAINDICATED PRODUCT ADMINISTERED 153 0.0050
218 RENAL CYST 40 0.0050
219 ARTHRITIS 394 0.0050
220 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 355 0.0050
221 PRE-EXISTING CONDITION IMPROVED 31 0.0050
222 SPINAL DISORDER 47 0.0050
223 RENAL DISORDER 230 0.0049
224 AORTIC VALVE INCOMPETENCE 21 0.0049
225 ANGINA PECTORIS 141 0.0049
226 MOUTH HAEMORRHAGE 36 0.0049
227 BRONCHIECTASIS 33 0.0049
228 ACUTE KIDNEY INJURY 749 0.0049
229 WHEEZING 289 0.0049
230 BURSITIS 59 0.0049
231 GASTROINTESTINAL MOTILITY DISORDER 26 0.0049
232 ALCOHOL POISONING 13 0.0048
233 PERICARDIAL EFFUSION 112 0.0048
234 BLOOD UREA INCREASED 80 0.0048
235 HUNGER 66 0.0047
236 DYSARTHRIA 176 0.0047
237 VARICOSE VEIN 24 0.0046
238 BLOOD IRON DECREASED 55 0.0046
239 FACET JOINT SYNDROME 15 0.0046
240 ATTENTION DEFICIT HYPERACTIVITY DISORDER 19 0.0045
241 MUSCLE TWITCHING 103 0.0045
242 AFFECTIVE DISORDER 35 0.0044
243 HYPERLIPIDAEMIA 53 0.0044
244 METABOLIC ACIDOSIS 139 0.0043
245 FLANK PAIN 40 0.0043
246 INFUSION SITE HAEMORRHAGE 14 0.0043
247 GASTROINTESTINAL TOXICITY 20 0.0042
248 TRICUSPID VALVE INCOMPETENCE 33 0.0041
249 LEFT VENTRICULAR FAILURE 14 0.0041
250 DRUG ERUPTION 72 0.0041
251 CHOLANGITIS 25 0.0040
252 JOINT RANGE OF MOTION DECREASED 54 0.0040
253 HIATUS HERNIA 52 0.0040
254 SENSITIVITY TO WEATHER CHANGE 21 0.0040
255 POLYARTHRITIS 21 0.0040
256 HAEMOGLOBIN INCREASED 18 0.0039
257 SKIN ULCER 102 0.0039
258 GLOSSITIS 14 0.0039
259 TOOTH DISORDER 87 0.0039
260 MUSCULAR WEAKNESS 441 0.0039
261 INCORRECT PRODUCT ADMINISTRATION DURATION 83 0.0038
262 FOETAL GROWTH RESTRICTION 23 0.0038
263 BUNDLE BRANCH BLOCK LEFT 16 0.0038
264 RENAL TUBULAR NECROSIS 37 0.0038
265 HYPERHIDROSIS 485 0.0038
266 CARDIAC FAILURE CHRONIC 16 0.0038
267 TRANSIENT ISCHAEMIC ATTACK 124 0.0037
268 SEASONAL ALLERGY 52 0.0037
269 RED BLOOD CELL COUNT DECREASED 105 0.0037
270 SINUS TACHYCARDIA 52 0.0037
271 COGNITIVE DISORDER 169 0.0036
272 IMPAIRED WORK ABILITY 77 0.0036
273 TINNITUS 165 0.0036
274 ANGIOPATHY 20 0.0036
275 PAIN OF SKIN 96 0.0036
276 IRON DEFICIENCY 16 0.0036
277 DIALYSIS 50 0.0035
278 FACIAL PARALYSIS 30 0.0035
279 RHEUMATOID ARTHRITIS 397 0.0035
280 BURNING SENSATION 245 0.0035
281 BLOOD PRESSURE SYSTOLIC INCREASED 68 0.0035
282 DYSPHAGIA 330 0.0035
283 ENCEPHALITIS 24 0.0035
284 CARDIAC MURMUR 30 0.0035
285 SINUSITIS 354 0.0035
286 DRUG LEVEL INCREASED 57 0.0034
287 DEFORMITY 32 0.0034
288 RASH MACULO-PAPULAR 76 0.0034
289 PROTEIN URINE PRESENT 17 0.0034
290 PULMONARY FIBROSIS 65 0.0034
291 BLOOD PRESSURE FLUCTUATION 81 0.0034
292 CATARACT 200 0.0034
293 BODY TEMPERATURE DECREASED 33 0.0033
294 INFUSION SITE ERYTHEMA 28 0.0033
295 PRODUCT ADMINISTRATION INTERRUPTED 26 0.0033
296 RHINORRHOEA 214 0.0033
297 HEPATIC CYTOLYSIS 42 0.0033
298 BENIGN PROSTATIC HYPERPLASIA 17 0.0033
299 IMPAIRED HEALING 108 0.0033
300 DYSPHONIA 192 0.0033
301 MITRAL VALVE INCOMPETENCE 37 0.0033
302 DRUG INTOLERANCE 315 0.0033
303 LIP SWELLING 108 0.0032
304 INJECTION SITE EXTRAVASATION 40 0.0032
305 HYPERCALCAEMIA 40 0.0032
306 ASTHMA 366 0.0032
307 SYNOVITIS 58 0.0032
308 BASAL CELL CARCINOMA 50 0.0032
309 DIVERTICULUM INTESTINAL 14 0.0032
310 SPINAL OSTEOARTHRITIS 28 0.0032
311 DERMATITIS BULLOUS 23 0.0032
312 HYPERURICAEMIA 13 0.0032
313 GASTROINTESTINAL DISORDER 283 0.0032
314 UPPER-AIRWAY COUGH SYNDROME 26 0.0032
315 RHEUMATIC FEVER 14 0.0031
316 NOCTURIA 38 0.0031
317 THERAPEUTIC PRODUCT EFFECT DECREASED 140 0.0031
318 EYE PRURITUS 105 0.0031
319 INTERSTITIAL LUNG DISEASE 151 0.0031
320 BLOOD ALKALINE PHOSPHATASE INCREASED 77 0.0031
321 ONYCHOMADESIS 13 0.0031
322 EYELID OEDEMA 36 0.0031
323 HYPOALBUMINAEMIA 24 0.0031
324 PHOTOPHOBIA 58 0.0031
325 NASAL CONGESTION 181 0.0031
326 RASH PAPULAR 69 0.0031
327 CONJUNCTIVITIS 57 0.0031
328 HYPERCHLORHYDRIA 18 0.0031
329 PRESCRIBED UNDERDOSE 61 0.0031
330 BLINDNESS 124 0.0030
331 PLEURISY 18 0.0030
332 PALPITATIONS 355 0.0030
333 HYPERTHERMIA 23 0.0030
334 PHARYNGOLARYNGEAL PAIN 16 0.0030
335 UPPER RESPIRATORY TRACT INFECTION 138 0.0030
336 SKIN PLAQUE 25 0.0030
337 TOXIC ENCEPHALOPATHY 15 0.0030
338 CARDIAC TAMPONADE 14 0.0029
339 IRON DEFICIENCY ANAEMIA 27 0.0029
340 SUPRAVENTRICULAR TACHYCARDIA 28 0.0029
341 HEPATITIS ACUTE 19 0.0029
342 MUSCULOSKELETAL STIFFNESS 256 0.0029
343 CHOLESTASIS 56 0.0029
344 NODULE 38 0.0029
345 HEPATIC STEATOSIS 54 0.0029
346 SOMNAMBULISM 19 0.0029
347 SWELLING FACE 188 0.0029
348 NASAL DRYNESS 18 0.0029
349 RESPIRATORY DISTRESS 79 0.0029
350 SERUM FERRITIN INCREASED 15 0.0028
351 RENAL FAILURE 377 0.0028
352 BUNDLE BRANCH BLOCK RIGHT 13 0.0028
353 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 29 0.0028
354 HYPERNATRAEMIA 14 0.0028
355 LUNG DISORDER 137 0.0028
356 TOXIC SKIN ERUPTION 28 0.0028
357 ANKLE FRACTURE 43 0.0028
358 TENDON RUPTURE 34 0.0028
359 HYPOCALCAEMIA 52 0.0027
360 PULMONARY OEDEMA 123 0.0027
361 OXYGEN SATURATION DECREASED 154 0.0027
362 DRY EYE 136 0.0027
363 APHTHOUS ULCER 21 0.0027
364 ATRIOVENTRICULAR BLOCK COMPLETE 18 0.0027
365 CARDIOMEGALY 33 0.0027
366 PROTEINURIA 51 0.0027
367 FOLLICULITIS 28 0.0027
368 INTENTIONAL PRODUCT USE ISSUE 233 0.0027
369 BLOOD ALBUMIN DECREASED 21 0.0026
370 CARDIAC DISORDER 244 0.0026
371 LUNG INFILTRATION 23 0.0026
372 MENISCUS INJURY 16 0.0026
373 BRUXISM 14 0.0026
374 CORONARY ARTERY STENOSIS 13 0.0026
375 EOSINOPHILIA 45 0.0026
376 MULTIPLE ALLERGIES 20 0.0025
377 LYMPHOCYTE COUNT DECREASED 45 0.0025
378 HYPERTENSION 539 0.0025
379 BLOOD CREATININE INCREASED 166 0.0025
380 DIVERTICULUM 18 0.0025
381 GASTRIC ULCER 48 0.0025
382 GINGIVAL PAIN 20 0.0025
383 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 43 0.0025
384 MUSCULOSKELETAL DISCOMFORT 43 0.0025
385 ABDOMINAL PAIN UPPER 514 0.0025
386 INFUSION RELATED REACTION 165 0.0025
387 DRUG-INDUCED LIVER INJURY 78 0.0025
388 INTERVERTEBRAL DISC DEGENERATION 23 0.0025
389 CROHN'S DISEASE 17 0.0025
390 LIPASE INCREASED 19 0.0025
391 RENAL FAILURE ACUTE 105 0.0025
392 VITAMIN D DECREASED 21 0.0025
393 COVID-19 PNEUMONIA 29 0.0025
394 THROAT IRRITATION 110 0.0024
395 DECREASED IMMUNE RESPONSIVENESS 24 0.0024
396 ACUTE RESPIRATORY FAILURE 47 0.0024
397 HYPOPHOSPHATAEMIA 18 0.0024
398 BACTERIAL INFECTION 45 0.0024
399 ISCHAEMIC STROKE 43 0.0024
400 ABDOMINAL DISCOMFORT 404 0.0024
401 MUSCULOSKELETAL PAIN 126 0.0024
402 EOSINOPHIL COUNT INCREASED 20 0.0024
403 LIVER DISORDER 106 0.0024
404 TYPE 2 DIABETES MELLITUS 80 0.0024
405 AGRANULOCYTOSIS 44 0.0024
406 HAND DEFORMITY 31 0.0024
407 ALANINE AMINOTRANSFERASE INCREASED 145 0.0024
408 HYPONATRAEMIA 133 0.0024
409 COUGH 662 0.0024
410 CHOKING SENSATION 13 0.0024
411 PHARYNGEAL SWELLING 23 0.0023
412 C-REACTIVE PROTEIN ABNORMAL 15 0.0023
413 HELICOBACTER INFECTION 24 0.0023
414 CONFUSIONAL STATE 376 0.0023
415 CONCUSSION 18 0.0023
416 BRONCHITIS 172 0.0023
417 HALLUCINATION 175 0.0023
418 AMNESIA 151 0.0023
419 SCIATICA 37 0.0023
420 FEELING JITTERY 44 0.0023
421 HEPATITIS 59 0.0023
422 INFLAMMATION 119 0.0023
423 JAUNDICE 62 0.0023
424 SKIN LACERATION 25 0.0023
425 HYPOKALAEMIA 106 0.0023
426 IMPAIRED QUALITY OF LIFE 33 0.0023
427 RASH PRURITIC 124 0.0023
428 JOINT STIFFNESS 60 0.0023
429 WOUND INFECTION 25 0.0023
430 EMPHYSEMA 23 0.0023
431 HYPERCHOLESTEROLAEMIA 22 0.0023
432 SEPTIC SHOCK 99 0.0023
433 WHITE BLOOD CELL COUNT INCREASED 87 0.0023
434 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17 0.0023
435 PAROSMIA 17 0.0023
436 OSTEOARTHRITIS 95 0.0022
437 HYPERSENSITIVITY 415 0.0022
438 DISTURBANCE IN ATTENTION 120 0.0022
439 PLATELET COUNT INCREASED 29 0.0022
440 PERIPHERAL SENSORY NEUROPATHY 13 0.0022
441 HYPERTRIGLYCERIDAEMIA 13 0.0022
442 BOWEL MOVEMENT IRREGULARITY 17 0.0022
443 OSTEOPOROSIS 91 0.0022
444 DEHYDRATION 295 0.0022
445 GAMMA-GLUTAMYLTRANSFERASE INCREASED 49 0.0022
446 DRUG INTERACTION 350 0.0022
447 GASTRITIS 58 0.0022
448 OVARIAN CYST 22 0.0022
449 INJECTION SITE IRRITATION 28 0.0022
450 POLYURIA 18 0.0022
451 NEUROPATHY PERIPHERAL 209 0.0022
452 MUSCULOSKELETAL CHEST PAIN 34 0.0022
453 HYPERAESTHESIA 18 0.0022
454 MIGRAINE 208 0.0022
455 ACCIDENT 26 0.0022
456 ATRIAL FIBRILLATION 212 0.0022
457 JOINT DISLOCATION 23 0.0022
458 PRODUCTIVE COUGH 103 0.0022
459 DUODENAL ULCER PERFORATION 16 0.0021
460 JOINT SWELLING 258 0.0021
461 EYE IRRITATION 123 0.0021
462 PANCREATITIS ACUTE 48 0.0021
463 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 117 0.0021
464 UNRESPONSIVE TO STIMULI 55 0.0021
465 ATRIAL FLUTTER 17 0.0021
466 HEART RATE INCREASED 211 0.0021
467 CHEST DISCOMFORT 217 0.0021
468 CARDIAC FAILURE CONGESTIVE 170 0.0021
469 HEPATOCELLULAR INJURY 30 0.0021
470 SPUTUM DISCOLOURED 20 0.0021
471 RESPIRATORY DISORDER 63 0.0021
472 HAEMOGLOBIN DECREASED 216 0.0021
473 GENERALISED OEDEMA 26 0.0021
474 CYST 26 0.0021
475 DRUG EFFECT LESS THAN EXPECTED 31 0.0021
476 LEFT VENTRICULAR DYSFUNCTION 14 0.0021
477 INFLUENZA 233 0.0021
478 CHEST PAIN 385 0.0021
479 ANXIETY 590 0.0021
480 HAEMOLYSIS 16 0.0021
481 DYSPNOEA EXERTIONAL 78 0.0021
482 INFUSION SITE SWELLING 13 0.0021
483 ELECTROLYTE IMBALANCE 24 0.0021
484 SUICIDE ATTEMPT 125 0.0021
485 SKIN EXFOLIATION 173 0.0020
486 LOWER RESPIRATORY TRACT INFECTION 93 0.0020
487 DYSPEPSIA 201 0.0020
488 EYE INFECTION 23 0.0020
489 PLEURAL EFFUSION 123 0.0020
490 DRY MOUTH 164 0.0020
491 BONE MARROW FAILURE 41 0.0020
492 QUALITY OF LIFE DECREASED 27 0.0020
493 FUNGAL INFECTION 67 0.0020
494 BACK PAIN 467 0.0020
495 ASCITES 59 0.0020
496 LYMPHOMA 31 0.0020
497 EYE PAIN 113 0.0020
498 HEPATIC ENZYME INCREASED 136 0.0020
499 HEADACHE 1250 0.0020
500 OROPHARYNGEAL DISCOMFORT 18 0.0020
501 INFLUENZA LIKE ILLNESS 164 0.0020
502 TACHYCARDIA 177 0.0020
503 NASOPHARYNGITIS 367 0.0020
504 ARTHRALGIA 827 0.0020
505 PAPULE 14 0.0020
506 GLYCOSYLATED HAEMOGLOBIN INCREASED 50 0.0020
507 TOXIC EPIDERMAL NECROLYSIS 30 0.0020
508 HEPATIC CIRRHOSIS 37 0.0020
509 HYPERKALAEMIA 69 0.0020
510 MUSCLE STRAIN 17 0.0020
511 INFECTION 284 0.0020
512 PNEUMONIA 635 0.0020
513 DYSURIA 72 0.0020
514 SWELLING 183 0.0020
515 CANDIDA INFECTION 33 0.0020
516 RENAL IMPAIRMENT 164 0.0020
517 CORONARY ARTERY DISEASE 59 0.0019
518 RHABDOMYOLYSIS 81 0.0019
519 INFUSION SITE PAIN 25 0.0019
520 POSTOPERATIVE WOUND INFECTION 13 0.0019
521 ACUTE RESPIRATORY DISTRESS SYNDROME 34 0.0019
522 OESOPHAGITIS 21 0.0019
523 ORAL PAIN 43 0.0019
524 HEART RATE DECREASED 67 0.0019
525 NEPHROTIC SYNDROME 13 0.0019
526 ASPARTATE AMINOTRANSFERASE INCREASED 100 0.0019
527 ANAPHYLACTIC REACTION 104 0.0019
528 ACUTE MYOCARDIAL INFARCTION 55 0.0019
529 EXOSTOSIS 17 0.0019
530 BLOOD SODIUM DECREASED 35 0.0019
531 FALL 615 0.0018
532 BLOOD THYROID STIMULATING HORMONE INCREASED 17 0.0018
533 MYOCLONUS 22 0.0018
534 BLOOD PRESSURE INCREASED 282 0.0018
535 ORAL HERPES 36 0.0018
536 PERIPHERAL SWELLING 284 0.0018
537 HAEMODYNAMIC INSTABILITY 14 0.0018
538 POOR VENOUS ACCESS 19 0.0018
539 MULTIPLE ORGAN DYSFUNCTION SYNDROME 52 0.0018
540 HEPATOMEGALY 18 0.0018
541 HERPES ZOSTER 105 0.0018
542 ESCHERICHIA INFECTION 15 0.0018
543 WEIGHT DECREASED 509 0.0018
544 CORONARY ARTERY OCCLUSION 25 0.0018
545 HEPATIC ENCEPHALOPATHY 17 0.0018
546 RENAL FAILURE CHRONIC 14 0.0018
547 MIDDLE INSOMNIA 34 0.0018
548 DYSPNOEA 1028 0.0018
549 PYREXIA 625 0.0018
550 CARDIAC FAILURE 145 0.0018
551 MOUTH ULCERATION 38 0.0018
552 PELVIC FRACTURE 14 0.0018
553 HYPOXIA 63 0.0018
554 JOINT INJURY 38 0.0018
555 MALAISE 780 0.0018
556 INTENTIONAL OVERDOSE 114 0.0018
557 PHARYNGITIS 22 0.0018
558 OEDEMA PERIPHERAL 216 0.0018
559 HEART RATE IRREGULAR 40 0.0018
560 CEREBROVASCULAR ACCIDENT 299 0.0018
561 HAEMATOCRIT DECREASED 35 0.0018
562 THERAPEUTIC RESPONSE DECREASED 107 0.0018
563 RESTLESS LEGS SYNDROME 32 0.0018
564 MYOCARDIAL ISCHAEMIA 20 0.0018
565 NAUSEA 1386 0.0017
566 PRODUCT USE IN UNAPPROVED INDICATION 434 0.0017
567 PSORIASIS 228 0.0017
568 PNEUMONIA BACTERIAL 16 0.0017
569 GLOSSODYNIA 39 0.0017
570 TREATMENT FAILURE 144 0.0017
571 MYOPATHY 15 0.0017
572 HYDRONEPHROSIS 13 0.0017
573 HYSTERECTOMY 15 0.0017
574 PYELONEPHRITIS 15 0.0017
575 PULMONARY HYPERTENSION 36 0.0017
576 RESPIRATORY FAILURE 126 0.0017
577 INTERNATIONAL NORMALISED RATIO INCREASED 49 0.0017
578 INJECTION SITE REACTION 118 0.0017
579 DIARRHOEA 1103 0.0017
580 ERUCTATION 33 0.0017
581 INSURANCE ISSUE 26 0.0017
582 PNEUMOCYSTIS JIROVECII PNEUMONIA 17 0.0017
583 PNEUMONIA ASPIRATION 42 0.0017
584 EJECTION FRACTION DECREASED 26 0.0017
585 COVID-19 293 0.0017
586 THERAPY NON-RESPONDER 75 0.0017
587 DERMATITIS CONTACT 19 0.0017
588 HEPATOTOXICITY 37 0.0017
589 SENSATION OF FOREIGN BODY 14 0.0017
590 EAR INFECTION 44 0.0017
591 ABDOMINAL PAIN 384 0.0016
592 HAEMOPTYSIS 46 0.0016
593 OSTEOPENIA 25 0.0016
594 INTERVERTEBRAL DISC PROTRUSION 36 0.0016
595 GASTROENTERITIS 24 0.0016
596 RETCHING 35 0.0016
597 GASTROINTESTINAL PAIN 18 0.0016
598 PSEUDOMONAS INFECTION 14 0.0016
599 NERVE COMPRESSION 15 0.0016
600 GRAND MAL CONVULSION 15 0.0016
601 URINARY INCONTINENCE 48 0.0016
602 INJECTION SITE INDURATION 21 0.0016
603 PAIN 990 0.0016
604 ILEUS 20 0.0016
605 HEPATIC FUNCTION ABNORMAL 60 0.0016
606 STAPHYLOCOCCAL INFECTION 53 0.0016
607 SKIN LESION 44 0.0016
608 BLOOD CALCIUM DECREASED 18 0.0016
609 BONE DENSITY DECREASED 50 0.0016
610 CHOLECYSTITIS 19 0.0016
611 HEPATIC FAILURE 48 0.0016
612 TUMOUR LYSIS SYNDROME 14 0.0016
613 DELIRIUM 55 0.0016
614 SYSTEMIC LUPUS ERYTHEMATOSUS 56 0.0016
615 RESPIRATORY RATE INCREASED 14 0.0016
616 CHOLECYSTECTOMY 18 0.0016
617 ARTHROPATHY 87 0.0016
618 HAEMOLYTIC ANAEMIA 14 0.0016
619 RIB FRACTURE 32 0.0016
620 PSORIATIC ARTHROPATHY 63 0.0016
621 DIVERTICULITIS 43 0.0016
622 VISUAL IMPAIRMENT 192 0.0015
623 HAEMODIALYSIS 13 0.0015
624 LIVER FUNCTION TEST ABNORMAL 45 0.0015
625 ASTHENIA 581 0.0015
626 GASTRIC DISORDER 53 0.0015
627 LACTIC ACIDOSIS 50 0.0015
628 HAEMATOMA 40 0.0015
629 EAR PAIN 30 0.0015
630 VENTRICULAR EXTRASYSTOLES 16 0.0015
631 NECK PAIN 86 0.0015
632 SUBDURAL HAEMATOMA 22 0.0015
633 SYNCOPE 153 0.0015
634 INTENTIONAL PRODUCT MISUSE 133 0.0015
635 LIMB DISCOMFORT 47 0.0015
636 ECONOMIC PROBLEM 23 0.0015
637 BACTERAEMIA 18 0.0015
638 BLOOD LACTATE DEHYDROGENASE INCREASED 24 0.0015
639 INCONTINENCE 16 0.0015
640 OROPHARYNGEAL PAIN 140 0.0015
641 BLOOD MAGNESIUM DECREASED 13 0.0015
642 DEPRESSED MOOD 79 0.0015
643 DISSEMINATED INTRAVASCULAR COAGULATION 21 0.0015
644 MICTURITION URGENCY 17 0.0015
645 CONDITION AGGRAVATED 452 0.0015
646 STOMATITIS 90 0.0015
647 ALTERED STATE OF CONSCIOUSNESS 32 0.0015
648 GRIP STRENGTH DECREASED 13 0.0015
649 PULMONARY MASS 22 0.0015
650 VOMITING 694 0.0015
651 BLOOD PRESSURE DECREASED 98 0.0015
652 IMMUNOSUPPRESSION 13 0.0015
653 BIPOLAR DISORDER 16 0.0015
654 URINARY TRACT INFECTION 251 0.0015
655 DIABETES MELLITUS 112 0.0015
656 WOUND 41 0.0015
657 RECTAL HAEMORRHAGE 63 0.0015
658 MEMORY IMPAIRMENT 201 0.0015
659 ANAEMIA 279 0.0015
660 INITIAL INSOMNIA 15 0.0015
661 WHITE BLOOD CELL COUNT DECREASED 158 0.0015
662 HERNIA 28 0.0014
663 PAIN IN JAW 41 0.0014
664 MYALGIA 246 0.0014
665 ELECTROCARDIOGRAM QT PROLONGED 52 0.0014
666 INTENTIONAL DOSE OMISSION 41 0.0014
667 HYPOTENSION 287 0.0014
668 PRURITUS 547 0.0014
669 BODY TEMPERATURE INCREASED 29 0.0014
670 HALLUCINATION, VISUAL 30 0.0014
671 LEUKOPENIA 71 0.0014
672 FATIGUE 1105 0.0014
673 PAIN IN EXTREMITY 418 0.0014
674 HYPOAESTHESIA 212 0.0014
675 DISCOMFORT 86 0.0014
676 GENERAL PHYSICAL HEALTH DETERIORATION 163 0.0014
677 NEUTROPHIL COUNT DECREASED 57 0.0014
678 OCULAR HYPERAEMIA 66 0.0014
679 GASTROENTERITIS VIRAL 25 0.0014
680 ARTERIOSCLEROSIS 13 0.0014
681 OBESITY 22 0.0014
682 HAEMATEMESIS 35 0.0014
683 FEELING ABNORMAL 330 0.0014
684 BLOOD GLUCOSE DECREASED 66 0.0014
685 BLOOD BILIRUBIN INCREASED 37 0.0014
686 IMMUNE SYSTEM DISORDER 18 0.0014
687 FACE OEDEMA 23 0.0014
688 DRY SKIN 182 0.0014
689 MELAENA 30 0.0014
690 VERTIGO 83 0.0014
691 PANCYTOPENIA 76 0.0014
692 BLOOD PRESSURE ABNORMAL 27 0.0014
693 ECZEMA 71 0.0014
694 INTESTINAL OBSTRUCTION 51 0.0014
695 BLOOD CHOLESTEROL INCREASED 63 0.0014
696 STEVENS-JOHNSON SYNDROME 30 0.0013
697 BLOOD GLUCOSE INCREASED 254 0.0013
698 SHOCK 31 0.0013
699 EYE DISCHARGE 14 0.0013
700 RESPIRATORY TRACT INFECTION 35 0.0013
701 RASH 584 0.0013
702 DEAFNESS 35 0.0013
703 WEIGHT FLUCTUATION 14 0.0013
704 INTESTINAL PERFORATION 15 0.0013
705 ROTATOR CUFF SYNDROME 17 0.0013
706 DRUG TOXICITY 18 0.0013
707 IMPAIRED GASTRIC EMPTYING 18 0.0013
708 BRADYCARDIA 70 0.0013
709 FOOT FRACTURE 25 0.0013
710 PULMONARY EMBOLISM 125 0.0013
711 LIGAMENT SPRAIN 13 0.0013
712 HAEMATURIA 45 0.0013
713 INSOMNIA 350 0.0013
714 DEEP VEIN THROMBOSIS 85 0.0013
715 UPPER GASTROINTESTINAL HAEMORRHAGE 22 0.0013
716 PRODUCT USE ISSUE 245 0.0013
717 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 68 0.0013
718 DEPRESSION 296 0.0013
719 SMALL INTESTINAL OBSTRUCTION 16 0.0013
720 BALANCE DISORDER 112 0.0013
721 BLOOD POTASSIUM INCREASED 21 0.0013
722 ORAL CANDIDIASIS 17 0.0013
723 APHONIA 18 0.0013
724 BACK INJURY 14 0.0013
725 BLOOD CREATINE PHOSPHOKINASE INCREASED 37 0.0013
726 FEEDING DISORDER 26 0.0013
727 PEMPHIGUS 16 0.0013
728 ALOPECIA 251 0.0013
729 FLATULENCE 72 0.0013
730 ROAD TRAFFIC ACCIDENT 53 0.0013
731 SEPSIS 141 0.0013
732 HEAD INJURY 40 0.0013
733 BRONCHOSPASM 18 0.0013
734 DISEASE RECURRENCE 60 0.0013
735 COMA 60 0.0013
736 ADVERSE EVENT 116 0.0013
737 OEDEMA 68 0.0013
738 HYPOPHAGIA 32 0.0013
739 PNEUMONITIS 34 0.0012
740 OCULAR DISCOMFORT 14 0.0012
741 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 32 0.0012
742 THROMBOSIS 100 0.0012
743 NIGHT SWEATS 40 0.0012
744 FEELING HOT 76 0.0012
745 THROMBOCYTOPENIA 138 0.0012
746 BACK DISORDER 20 0.0012
747 FLUSHING 125 0.0012
748 SKIN DISORDER 41 0.0012
749 CHILLS 144 0.0012
750 CEREBRAL INFARCTION 30 0.0012
751 CYTOPENIA 15 0.0012
752 FEBRILE NEUTROPENIA 81 0.0012
753 CHOLELITHIASIS 40 0.0012
754 SLEEP DISORDER 86 0.0012
755 BODY HEIGHT DECREASED 13 0.0012
756 INJECTION SITE WARMTH 25 0.0012
757 LYMPHADENOPATHY 43 0.0012
758 DISORIENTATION 48 0.0012
759 COLITIS ULCERATIVE 54 0.0012
760 DECREASED ACTIVITY 13 0.0012
761 DIZZINESS 601 0.0012
762 PLATELET COUNT DECREASED 128 0.0012
763 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 216 0.0012
764 SPINAL FRACTURE 24 0.0012
765 BLOOD POTASSIUM DECREASED 36 0.0012
766 BLOOD TRIGLYCERIDES INCREASED 21 0.0012
767 OFF LABEL USE 1038 0.0012
768 TASTE DISORDER 24 0.0012
769 EPILEPSY 36 0.0012
770 RASH MACULAR 41 0.0012
771 MULTIPLE SCLEROSIS 56 0.0012
772 ACUTE HEPATIC FAILURE 16 0.0012
773 GOUT 21 0.0012
774 POLYNEUROPATHY 14 0.0012
775 IRRITABLE BOWEL SYNDROME 25 0.0012
776 PARAESTHESIA 183 0.0012
777 DISABILITY 23 0.0012
778 FLUID RETENTION 59 0.0012
779 DELUSION 18 0.0012
780 NEPHROPATHY TOXIC 13 0.0012
781 DYSGEUSIA 86 0.0012
782 ERYTHEMA 237 0.0012
783 PRESYNCOPE 28 0.0012
784 IMPAIRED DRIVING ABILITY 13 0.0011
785 CYTOMEGALOVIRUS INFECTION 19 0.0011
786 CELLULITIS 57 0.0011
787 ABDOMINAL DISTENSION 118 0.0011
788 URTICARIA 189 0.0011
789 HOSPITALISATION 173 0.0011
790 SKIN FISSURES 22 0.0011
791 TOOTH EXTRACTION 14 0.0011
792 DRUG INEFFECTIVE 1481 0.0011
793 ILLNESS 115 0.0011
794 POOR QUALITY SLEEP 24 0.0011
795 VIRAL INFECTION 37 0.0011
796 FREQUENT BOWEL MOVEMENTS 30 0.0011
797 NEURALGIA 27 0.0011
798 THROAT TIGHTNESS 30 0.0011
799 COLITIS 42 0.0011
800 FAECES DISCOLOURED 24 0.0011
801 BLOOD URINE PRESENT 21 0.0011
802 HAEMATOCHEZIA 61 0.0011
803 LEUKOCYTOSIS 20 0.0011
804 ANHEDONIA 29 0.0011
805 POLLAKIURIA 46 0.0011
806 LIVER INJURY 27 0.0011
807 WEIGHT INCREASED 246 0.0011
808 BONE DISORDER 20 0.0011
809 ACCIDENTAL OVERDOSE 40 0.0011
810 LOSS OF CONSCIOUSNESS 140 0.0011
811 GLAUCOMA 21 0.0011
812 ANOREXIA 14 0.0011
813 TRANSAMINASES INCREASED 24 0.0011
814 URINARY RETENTION 36 0.0011
815 MYOCARDIAL INFARCTION 188 0.0011
816 CHOKING 21 0.0011
817 HOT FLUSH 81 0.0011
818 SURGERY 63 0.0011
819 PNEUMOTHORAX 17 0.0011
820 PANIC ATTACK 39 0.0011
821 LIMB INJURY 29 0.0011
822 SKIN DISCOLOURATION 49 0.0011
823 THIRST 19 0.0011
824 CONSTIPATION 231 0.0011
825 GLOMERULAR FILTRATION RATE DECREASED 13 0.0011
826 THERAPEUTIC RESPONSE SHORTENED 35 0.0011
827 CLOSTRIDIUM DIFFICILE INFECTION 23 0.0011
828 HYPOGLYCAEMIA 51 0.0011
829 DECREASED APPETITE 244 0.0010
830 RASH ERYTHEMATOUS 50 0.0010
831 POST PROCEDURAL COMPLICATION 20 0.0010
832 MULTI-ORGAN FAILURE 18 0.0010
833 PARAESTHESIA ORAL 15 0.0010
834 DEMENTIA 29 0.0010
835 NEOPLASM PROGRESSION 36 0.0010
836 PRODUCT TASTE ABNORMAL 14 0.0010
837 MUCOSAL INFLAMMATION 27 0.0010
838 TACHYPNOEA 14 0.0010
839 VISION BLURRED 141 0.0010
840 GASTRIC CANCER 26 0.0010
841 HIP FRACTURE 33 0.0010
842 ENCEPHALOPATHY 25 0.0010
843 HEAD DISCOMFORT 18 0.0010
844 PRODUCT DOSE OMISSION ISSUE 298 0.0010
845 ANAPHYLACTIC SHOCK 26 0.0010
846 INCORRECT DOSE ADMINISTERED 230 0.0010
847 CONTUSION 96 0.0010
848 CYTOKINE RELEASE SYNDROME 20 0.0010
849 NEEDLE ISSUE 29 0.0010
850 HYPOAESTHESIA ORAL 15 0.0010
851 MOBILITY DECREASED 71 0.0010
852 MUSCLE TIGHTNESS 16 0.0010
853 GAIT INABILITY 33 0.0010
854 ANKYLOSING SPONDYLITIS 13 0.0010
855 LIVER FUNCTION TEST INCREASED 21 0.0010
856 CARDIOGENIC SHOCK 14 0.0010
857 HYPERTHYROIDISM 14 0.0010
858 LUNG INFECTION 15 0.0010
859 PANCREATITIS 51 0.0010
860 MUSCLE SPASMS 177 0.0010
861 THERAPY PARTIAL RESPONDER 15 0.0010
862 DERMATITIS 20 0.0010
863 IMMUNODEFICIENCY 14 0.0009
864 FEMUR FRACTURE 29 0.0009
865 SENSORY DISTURBANCE 15 0.0009
866 SOMNOLENCE 188 0.0009
867 PRURITUS GENERALISED 20 0.0009
868 DEVICE OCCLUSION 13 0.0009
869 HAEMORRHOIDS 18 0.0009
870 BLOOD GLUCOSE ABNORMAL 17 0.0009
871 MANIA 15 0.0009
872 LOCALISED INFECTION 22 0.0009
873 ABDOMINAL PAIN LOWER 23 0.0009
874 HYPERGLYCAEMIA 33 0.0009
875 INJECTION SITE HAEMATOMA 13 0.0009
876 FULL BLOOD COUNT DECREASED 18 0.0009
877 ADVERSE DRUG REACTION 80 0.0009
878 CHROMATURIA 20 0.0009
879 NEOPLASM MALIGNANT 59 0.0009
880 OSTEONECROSIS 29 0.0009
881 MEDICATION ERROR 49 0.0009
882 MOVEMENT DISORDER 28 0.0009
883 ABNORMAL DREAMS 24 0.0009
884 ORTHOSTATIC HYPOTENSION 15 0.0009
885 CARDIAC ARREST 71 0.0009
886 DEPRESSED LEVEL OF CONSCIOUSNESS 34 0.0009
887 AGITATION 63 0.0009
888 FEAR 23 0.0009
889 METASTASES TO LIVER 15 0.0009
890 UPPER LIMB FRACTURE 17 0.0009
891 LETHARGY 49 0.0009
892 GASTROINTESTINAL HAEMORRHAGE 71 0.0008
893 FRACTURE 16 0.0008
894 DEVICE RELATED INFECTION 13 0.0008
895 INCREASED APPETITE 16 0.0008
896 HYPERSOMNIA 24 0.0008
897 TREMOR 138 0.0008
898 EPISTAXIS 62 0.0008
899 LACRIMATION INCREASED 25 0.0008
900 ARRHYTHMIA 39 0.0008
901 HALLUCINATION, AUDITORY 13 0.0008
902 EXPOSURE VIA SKIN CONTACT 21 0.0008
903 NEUTROPENIA 108 0.0008
904 GAIT DISTURBANCE 151 0.0008
905 PERITONITIS 16 0.0008
906 PALLOR 21 0.0008
907 PELVIC PAIN 14 0.0008
908 CONVULSION 44 0.0008
909 BONE PAIN 45 0.0008
910 PRODUCT SUBSTITUTION ISSUE 44 0.0008
911 CIRCULATORY COLLAPSE 13 0.0008
912 MENTAL STATUS CHANGES 21 0.0008
913 DYSSTASIA 22 0.0008
914 BLISTER 42 0.0007
915 PRODUCT AVAILABILITY ISSUE 17 0.0007
916 WRONG TECHNIQUE IN DRUG USAGE PROCESS 27 0.0007
917 PRODUCT DOSE OMISSION IN ERROR 21 0.0007
918 RESTLESSNESS 27 0.0007
919 INJECTION SITE MASS 27 0.0007
920 EYE SWELLING 27 0.0007
921 KNEE ARTHROPLASTY 15 0.0007
922 ILL-DEFINED DISORDER 43 0.0007
923 SPEECH DISORDER 37 0.0007
924 CARDIO-RESPIRATORY ARREST 29 0.0007
925 OVERDOSE 147 0.0007
926 LOWER LIMB FRACTURE 13 0.0007
927 INJECTION SITE PRURITUS 45 0.0007
928 MYELOSUPPRESSION 24 0.0007
929 ERECTILE DYSFUNCTION 17 0.0007
930 MOOD ALTERED 18 0.0007
931 TREATMENT NONCOMPLIANCE 36 0.0007
932 PSYCHOTIC DISORDER 19 0.0006
933 NERVOUSNESS 33 0.0006
934 INJECTION SITE PAIN 190 0.0006
935 FEELING COLD 17 0.0006
936 DERMATITIS ATOPIC 32 0.0006
937 MENTAL DISORDER 26 0.0006
938 MATERNAL EXPOSURE DURING PREGNANCY 53 0.0006
939 INJECTION SITE RASH 18 0.0006
940 SUICIDAL IDEATION 53 0.0006
941 UNDERDOSE 42 0.0006
942 HAEMORRHAGE 59 0.0006
943 HYPOACUSIS 24 0.0006
944 EYE DISORDER 18 0.0005
945 DIABETIC KETOACIDOSIS 13 0.0005
946 PROCEDURAL PAIN 15 0.0005
947 INJECTION SITE ERYTHEMA 67 0.0005
948 MALIGNANT NEOPLASM PROGRESSION 55 0.0005
949 PRODUCT DOSE OMISSION 35 0.0005
950 INCORRECT DRUG ADMINISTRATION DURATION 15 0.0005
951 INJECTION SITE URTICARIA 13 0.0005
952 DRUG EFFECT INCOMPLETE 19 0.0005
953 TOXICITY TO VARIOUS AGENTS 88 0.0005
954 CEREBRAL HAEMORRHAGE 18 0.0005
955 SKIN BURNING SENSATION 36 0.0005
956 UNEVALUABLE EVENT 38 0.0005
957 EXPOSURE DURING PREGNANCY 31 0.0005
958 INJECTION SITE SWELLING 37 0.0005
959 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 96 0.0005
960 BREAST CANCER 44 0.0005
961 MOOD SWINGS 15 0.0005
962 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
963 DYSKINESIA 19 0.0005
964 INJECTION SITE BRUISING 37 0.0005
965 LUNG NEOPLASM MALIGNANT 19 0.0005
966 THERAPY INTERRUPTED 33 0.0005
967 PLASMA CELL MYELOMA 18 0.0005
968 DISEASE PROGRESSION 54 0.0005
969 NERVOUS SYSTEM DISORDER 14 0.0004
970 EXTRA DOSE ADMINISTERED 18 0.0004
971 AGGRESSION 21 0.0004
972 ABNORMAL BEHAVIOUR 16 0.0004
973 EMOTIONAL DISTRESS 48 0.0004
974 FOETAL EXPOSURE DURING PREGNANCY 32 0.0004
975 SEIZURE 45 0.0004
976 CRYING 14 0.0004
977 ANGER 13 0.0004
978 DEATH 325 0.0004
979 COMPLETED SUICIDE 31 0.0004
980 INJECTION SITE HAEMORRHAGE 28 0.0004
981 INJURY 24 0.0003
982 DEVICE ISSUE 29 0.0003
983 MULTIPLE SCLEROSIS RELAPSE 22 0.0003
984 IRRITABILITY 18 0.0003
985 DRUG ABUSE 24 0.0003
986 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20 0.0003
987 DRUG DOSE OMISSION 43 0.0003
988 DRUG EFFECT DECREASED 14 0.0003
989 ACNE 19 0.0003
990 PRODUCT QUALITY ISSUE 33 0.0002
991 DEVICE MALFUNCTION 16 0.0002
992 NO ADVERSE EVENT 38 0.0002
993 DRUG WITHDRAWAL SYNDROME 14 0.0002
994 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
995 DRUG DEPENDENCE 21 0.0001